Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials.
作者:
主题词
临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);疾病恶化(Disease Progression);终点测定(Endpoint Determination);人类(Humans);特发性肺纤维化(Idiopathic Pulmonary Fibrosis);随机对照试验(主题)(Randomized Controlled Trials as Topic);结果可重复性(Reproducibility of Results);肺活量(Vital Capacity)
DOI
10.1164/rccm.201206-1010PP
PMID
22798316
发布时间
2022-03-21
- 浏览18
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文